Apabetalone (RVX-208) CAS:1044870-39-4 is a bromodomain and ectoterminal protein inhibitor (BETi), bromo- and ectoterminal (BET) proteins have distinct roles in regulating tissue-specific transcriptional programs, leading to the safety of their inhibition sex issues, and suggest that targeting specific isoforms or even specific domains within this subfamily is important. Apabetalone binds to the acetyl-lysine binding pocket in a peptide-competitive manner, which is responsible for its pharmacological activity.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
